Cancer services are beginning to get up and running across the country, but we’re still a long way from either restoring capacity or addressing the backlog of people waiting for tests and treatment.
A new breed of targeted cancer drug has been approved for NHS use in England. But drugs like larotrectinib also pose unique and complex challenges for the NHS, which have been exacerbated by the COVID-19 pandemic.
Cancer services have been severely disrupted across the UK, from screening to treatment and care.
What do the latest recommendations from Sir Mike Richards mean for screening in England? We take a look.
Waiting to hear if you have cancer, or if your cancer has come back, can be an extremely stressful time – especially if the results take weeks to come back.
Diagnosing cancer at its earliest and most treatable stages is vital to help more people survive their cancer. But it requires having enough NHS staff in place.
The new Government have made several announcements about science and the NHS, including a new Artificial Intelligence lab. But what does it mean for cancer?
With a new Prime Minister in office, the Government’s commitments to supporting the NHS and building on the strength of science in the UK must become reality.
Researchers have gathered the most complete picture of how long people wait for a cancer diagnosis in England. And there’s huge variation between referrals.